FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008305834> ?p ?o ?g. }

• W2008305834 abstract "Women with breast cancer, particularly individuals diagnosed at a relatively early age, have an increased incidence of fractures. Fractures can have serious clinical consequences including the need for major surgery, increased morbidity and mortality, increased cost of disease management, and reduced quality of life for patients. The primary cause of the increased fracture risk appears to be an accelerated decrease in bone mineral density (BMD) resulting from the loss of estrogenic signaling that occurs with most treatments for breast cancer, including aromatase inhibitors. However, factors other than BMD levels alone may influence treatment decisions to reduce fracture risk in this setting. Our purpose is to review current evidence for BMD loss and fracture risk during treatment for breast cancer and discuss pharmacologic means to reduce this risk. Fracture risk during treatment for breast cancer may be influenced by the rate of BMD loss and the consequent rapid alterations in bone microarchitecture, in addition to the established fracture risk factors in postmenopausal osteoporosis. The rapid decrease in BMD during adjuvant chemoendocrine therapy for breast cancer may necessitate more aggressive pharmacotherapy than is indicated for healthy postmenopausal women who develop osteoporosis. Over the last few years, clinical trials have established the effectiveness of bisphosphonates and other antiresorptive agents to preserve BMD during adjuvant therapy for early breast cancer. In addition, some bisphosphonates (eg, zoledronic acid) may also delay disease recurrence in women with hormone-responsive tumors, thereby providing an adjuvant benefit in addition to preserving BMD and potentially preventing fractures. It is likely that a combined fracture risk assessment (eg, as in the WHO FRAX algorithm) will more accurately identify both women with postmenopausal osteoporosis and women with breast cancer who require bone-protective therapy." @default.
• W2008305834 created "2016-06-24" @default.
• W2008305834 creator A5053293171 @default.
• W2008305834 date "2011-08-29" @default.
• W2008305834 modified "2023-10-17" @default.
• W2008305834 title "Increased fracture rate in women with breast cancer: a review of the hidden risk" @default.
• W2008305834 cites W1531964529 @default.
• W2008305834 cites W1600148698 @default.
• W2008305834 cites W1964891491 @default.
• W2008305834 cites W1966741541 @default.
• W2008305834 cites W1969514242 @default.
• W2008305834 cites W1969598376 @default.
• W2008305834 cites W1971653725 @default.
• W2008305834 cites W1976680910 @default.
• W2008305834 cites W1979115901 @default.
• W2008305834 cites W1989622431 @default.
• W2008305834 cites W1991611758 @default.
• W2008305834 cites W1999899903 @default.
• W2008305834 cites W2006131871 @default.
• W2008305834 cites W2016804049 @default.
• W2008305834 cites W2021280621 @default.
• W2008305834 cites W2027214144 @default.
• W2008305834 cites W2033305008 @default.
• W2008305834 cites W2034606501 @default.
• W2008305834 cites W2034700061 @default.
• W2008305834 cites W2044147129 @default.
• W2008305834 cites W2051399396 @default.
• W2008305834 cites W2054727157 @default.
• W2008305834 cites W2068530253 @default.
• W2008305834 cites W2074791841 @default.
• W2008305834 cites W2079161020 @default.
• W2008305834 cites W2088014747 @default.
• W2008305834 cites W2107118598 @default.
• W2008305834 cites W2109526747 @default.
• W2008305834 cites W2112780046 @default.
• W2008305834 cites W2113697838 @default.
• W2008305834 cites W2116605720 @default.
• W2008305834 cites W2122911205 @default.
• W2008305834 cites W2128578828 @default.
• W2008305834 cites W2139796029 @default.
• W2008305834 cites W2139959697 @default.
• W2008305834 cites W2143151890 @default.
• W2008305834 cites W2146810449 @default.
• W2008305834 cites W2148096512 @default.
• W2008305834 cites W2148226416 @default.
• W2008305834 cites W2156938611 @default.
• W2008305834 cites W2158786144 @default.
• W2008305834 cites W2162254379 @default.
• W2008305834 cites W2163873353 @default.
• W2008305834 cites W2171595133 @default.
• W2008305834 cites W2322274315 @default.
• W2008305834 cites W4236203212 @default.
• W2008305834 doi "https://doi.org/10.1186/1471-2407-11-384" @default.
• W2008305834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3175226" @default.
• W2008305834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21875433" @default.
• W2008305834 hasPublicationYear "2011" @default.
• W2008305834 type Work @default.
• W2008305834 sameAs 2008305834 @default.
• W2008305834 citedByCount "65" @default.
• W2008305834 countsByYear W20083058342012 @default.
• W2008305834 countsByYear W20083058342013 @default.
• W2008305834 countsByYear W20083058342014 @default.
• W2008305834 countsByYear W20083058342015 @default.
• W2008305834 countsByYear W20083058342016 @default.
• W2008305834 countsByYear W20083058342017 @default.
• W2008305834 countsByYear W20083058342018 @default.
• W2008305834 countsByYear W20083058342019 @default.
• W2008305834 countsByYear W20083058342020 @default.
• W2008305834 countsByYear W20083058342021 @default.
• W2008305834 countsByYear W20083058342022 @default.
• W2008305834 countsByYear W20083058342023 @default.
• W2008305834 crossrefType "journal-article" @default.
• W2008305834 hasAuthorship W2008305834A5053293171 @default.
• W2008305834 hasBestOaLocation W20083058341 @default.
• W2008305834 hasConcept C121608353 @default.
• W2008305834 hasConcept C126322002 @default.
• W2008305834 hasConcept C141071460 @default.
• W2008305834 hasConcept C143998085 @default.
• W2008305834 hasConcept C2776166826 @default.
• W2008305834 hasConcept C2776326535 @default.
• W2008305834 hasConcept C2776541429 @default.
• W2008305834 hasConcept C2776886416 @default.
• W2008305834 hasConcept C2777982462 @default.
• W2008305834 hasConcept C2778504769 @default.
• W2008305834 hasConcept C2780140570 @default.
• W2008305834 hasConcept C530470458 @default.
• W2008305834 hasConcept C71924100 @default.
• W2008305834 hasConceptScore W2008305834C121608353 @default.
• W2008305834 hasConceptScore W2008305834C126322002 @default.
• W2008305834 hasConceptScore W2008305834C141071460 @default.
• W2008305834 hasConceptScore W2008305834C143998085 @default.
• W2008305834 hasConceptScore W2008305834C2776166826 @default.
• W2008305834 hasConceptScore W2008305834C2776326535 @default.
• W2008305834 hasConceptScore W2008305834C2776541429 @default.
• W2008305834 hasConceptScore W2008305834C2776886416 @default.
• W2008305834 hasConceptScore W2008305834C2777982462 @default.
• W2008305834 hasConceptScore W2008305834C2778504769 @default.
• W2008305834 hasConceptScore W2008305834C2780140570 @default.
• W2008305834 hasConceptScore W2008305834C530470458 @default.
• W2008305834 hasConceptScore W2008305834C71924100 @default.

• next